Intestinal microbiome from AOS treatment mice-4
MIGS/MIMS/MIMARKS.host-associated
BioSampleModel
MIMARKS.survey
BioSampleModel
2023-11-28T00:09:40Z
ENA-FIRST-PUBLIC
2023-11-28T00:09:40Z
ENA-LAST-UPDATE
SAMN38440851
External Id
pda|zhang_and_wang_lab
INSDC center name
2023-11-28T00:09:40Z
INSDC first public
2023-11-28T00:09:40Z
INSDC last update
public
INSDC status
SRS19642451
SRA accession
Intestinal microbiome from AOS treatment mice-4
Submitter Id
NCBI
broker name
2021-08
collection_date
In this study, we showed that BPS exposure induced dysbiosis of gut microbiota, which further resulted in intestinal permeability and inflammation, and ultimately damaged oocyte quality. More importantly, we found that alginate oligosaccharide (AOS) reshapes the intestinal microbiota to improve intestinal homeostasis and thus prevents the deleterious effects of BPS on intestine and oocytes. 16S rRNA reads from intestinal microbiome of CD-1 mice with BPS or AOS or AOS/BPS or without AOS/BPS treatment. We also detected intestinal microbiome of faecal microbiota transplanted from BPS or without BPS treated mice.
description
not applicable
env_broad_scale
not applicable
env_local_scale
Intestine
env_medium
China:jinan
geo_loc_name
Mus musculus
host
36.40 N 117 E
lat_lon
mouse gut metagenome
organism
mouse gut metagenome
scientific_name
MIMARKS Survey related sample from mouse gut metagenome
title